Great Point Partners LLC Evolus, Inc. Transaction History
Great Point Partners LLC
- $152 Million
- Q4 2024
A detailed history of Great Point Partners LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Great Point Partners LLC holds 895,524 shares of EOLS stock, worth $12.7 Million. This represents 6.52% of its overall portfolio holdings.
Number of Shares
895,524
Previous 1,170,000
23.46%
Holding current value
$12.7 Million
Previous $19 Million
47.84%
% of portfolio
6.52%
Previous 8.76%
Shares
9 transactions
Others Institutions Holding EOLS
# of Institutions
169Shares Held
48.8MCall Options Held
57.2KPut Options Held
5.5K-
Perceptive Advisors LLC New York, NY5.15MShares$72.9 Million1.9% of portfolio
-
Tang Capital Management LLC San Diego, CA5MShares$70.8 Million4.14% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$56.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.17MShares$44.9 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.13MShares$44.4 Million1.74% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $795M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...